Stoke Therapeutics, Inc.
2020 Q1 - 2025 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 430 | 0.0% | 13,550 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 171 | 0.0% | 15,099 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 88 | 0.0% | 13,237 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 147 | 0.0% | 13,304 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 167 | 0.0% | 13,618 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 189 | 0.0% | 13,964 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 162 | 0.0% | 11,970 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 63 | 0.0% | 11,916 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 47 | 0.0% | 11,916 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 502 | 0.0% | 47,271 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 376 | 0.0% | 45,152 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 410 | 0.0% | 45,152 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 587 | 0.0% | 45,185 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 603 | 0.0% | 45,529 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 755 | 0.0% | 34,499 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 262 | 0.0% | 10,901 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 272 | 0.0% | 10,683 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 385 | 0.0% | 11,440 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 318 | 0.0% | 8,196 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 489 | 0.0% | 7,896 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 255 | 0.0% | 7,620 | 9/30/2020 |
| 2020 Q1 | 5/15/2020 | 243 | 0.0% | 10,603 | 3/31/2020 |